Vitamin D in children with cystic fibrosis

Malcolm Brodlie1, William A Orchard, Gordon A Reeks

  • 1Paediatric Respiratory Secretaries, Old Children's Outpatients Department, Royal Victoria Infirmary, Newcastle upon Tyne, UK. m.j.brodlie@ncl.ac.uk

Insights

Increased vitamin D supplementation significantly improved 25-hydroxyvitamin D levels in cystic fibrosis children. However, many pancreatic insufficient children still did not reach the recommended target levels.

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Science
  • Cystic Fibrosis Research

Background:

  • The Cystic Fibrosis Trust established a 2007 target of 75-150 nmol/L for 25-hydroxyvitamin D (25-OHD).
  • A 2008 audit revealed only 10% of pancreatic insufficient (PI) cystic fibrosis children met this target.

Purpose of the Study:

  • To assess the impact of increased vitamin D supplementation on 25-OHD levels in PI children.
  • To evaluate 25-OHD levels in pancreatic sufficient (PS) children in 2010.

Main Methods:

  • PI children (≥1 year) under sole-care received significantly increased Vitamin D3 supplementation (>450%).
  • Supplementation regimens included 3800 IU/day liquid or 800 IU daily plus 20,000 IU weekly tablets.
  • Pancreatic sufficient (PS) children were audited separately in 2010.

Main Results:

  • The median 25-OHD level in PI children rose from 51.5 nmol/L in 2008 to 72 nmol/L in 2010 (p<0.0001).
  • The percentage of PI children achieving >75 nmol/L increased from 10% in 2008 to 51% in 2010.
  • In 2010, 87% of PS children (n=15) had 25-OHD levels below 75 nmol/L.

Conclusions:

  • A substantial increase in vitamin D supplementation significantly improved 25-OHD levels in PI cystic fibrosis children.
  • Despite the increase, approximately half of the PI children did not reach the recommended 75 nmol/L target.
  • The majority of PS children had insufficient 25-OHD levels, indicating a broader issue.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin D3(cholecalciferol).
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced in our...